Vertigo Market Analysis, Emerging Therapies and Key Pharma Players Involved by DelveInsight | Auris Medical, Sensorion, Apsen Farmaceutica, Otonomy, Sound Pharmaceuticals and Others.

Vertigo Market

Vertigo is a symptom, rather than a condition itself. It’s the sensation that you, or the environment around you, is moving or spinning. This feeling may be barely noticeable, or it may be so severe that you find it difficult to keep your balance and do everyday tasks. Attacks of vertigo can develop suddenly and last for a few seconds, or they may last much longer. If you have severe vertigo, your symptoms may be constant and last for several days, making normal life very difficult. Vertigo is commonly caused by a problem with the way balance works in the inner ear, although it can also be caused by problems in certain parts of the brain. Some cases of vertigo improve over time, without treatment.

DelveInsight’s, Vertigo Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Vertigo pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.


Some of Vertigo Companies are:

Auris Medical
Apsen Farmaceutica
Sound Pharmaceuticals
And Many Others


Request for Free Sample Report


DelveInsight’s Vertigo report covers around 3+ products under different phases of clinical development like:

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration


Some of Vertigo Therapies are:

And Many Others


Request for Free Sample Report:


Current Vertigo Treatment Scenario and Vertigo Emerging Therapies:

How many companies are developing Vertigo drugs?
How many Vertigo drugs are developed by each company?
How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Vertigo?
What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Vertigo therapeutics?
What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
What are the clinical studies going on for Vertigo and their status?
What are the key designations that have been granted to the emerging drugs?


Request for Free Sample Report:


Table of Contents:


Executive Summary

Vertigo: Overview

Pipeline Therapeutics

Comparative Analysis

Therapeutic Assessment

Vertigo – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

Vertigo Collaboration Deals

Mid Stage Products (Phase II)

Comparative Analysis

AM-125: Auris Medical

Drug profiles in the detailed report…..

Early Stage Products (Phase I) 

Comparative Analysis

APSLXR: Apsen Farmaceutica

Drug profiles in the detailed report…..

Inactive Products

Comparative Analysis

Vertigo Key Companies

Vertigo Key Products

Vertigo- Unmet Needs

Vertigo- Market Drivers and Barriers

Vertigo- Future Perspectives and Conclusion

Vertigo Analyst Views

Vertigo Key Companies



About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States